Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects.
Publication
, Journal Article
Yeung, H; Supapannachart, KJ; Cole, EF; Chen, SC
Published in: J Cutan Med Surg
2022
Duke Scholars
Published In
J Cutan Med Surg
DOI
EISSN
1615-7109
Publication Date
2022
Volume
26
Issue
2
Start / End Page
212 / 213
Location
United States
Related Subject Headings
- Surveys and Questionnaires
- Skin
- Quality of Life
- Melanoma
- Immunotherapy
- Humans
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yeung, H., Supapannachart, K. J., Cole, E. F., & Chen, S. C. (2022). Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects. J Cutan Med Surg, 26(2), 212–213. https://doi.org/10.1177/12034754211051239
Yeung, Howa, Krittin J. Supapannachart, Emily F. Cole, and Suephy C. Chen. “Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects.” J Cutan Med Surg 26, no. 2 (2022): 212–13. https://doi.org/10.1177/12034754211051239.
Yeung H, Supapannachart KJ, Cole EF, Chen SC. Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects. J Cutan Med Surg. 2022;26(2):212–3.
Yeung, Howa, et al. “Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects.” J Cutan Med Surg, vol. 26, no. 2, 2022, pp. 212–13. Pubmed, doi:10.1177/12034754211051239.
Yeung H, Supapannachart KJ, Cole EF, Chen SC. Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects. J Cutan Med Surg. 2022;26(2):212–213.
Published In
J Cutan Med Surg
DOI
EISSN
1615-7109
Publication Date
2022
Volume
26
Issue
2
Start / End Page
212 / 213
Location
United States
Related Subject Headings
- Surveys and Questionnaires
- Skin
- Quality of Life
- Melanoma
- Immunotherapy
- Humans
- Dermatology & Venereal Diseases
- 3202 Clinical sciences